Product information per respective product insert. Viscosity measurements vary per methods reported in respective product package insert.

• High viscosity for increased anterior chamber expansion and maintenance
• Highest molecular weight of any ophthalmic viscoelastic device on the market^1,2
• Expands anterior chamber and flattens anterior capsule to facilitate capsulorrhexis

• Long molecular chain designed to facilitate removal
• Latex-free
• Cohesive

Produced considerably less mean endothelial cell loss than VISCOAT® OVD and Ocucoat® OVD

References

1. Hütz WW, Eckhardt HB, Kohnen T. Comparison of viscoelastic substances used in phacoemulsification. J Cataract Refract Surg. 1996;22(11):955-959.
2. Data on file, Advanced Medical Optics, Inc.
3. Buratto L, Giardini P, Bellucci R. Viscoelastics In Ophthalmic Surgery. Thorofare, NJ: Slack Inc; 2005:5.
4. Holmen J JB, Lundgren B. Scheimpflug photography study of ophthalmic viscosurgical devices during simulated cataract surgery. J Cataract Refract Surg. 2003;29(3):568-574.
5. Claesson M. A comparative study between Healon5 and Viscoat. Paper presented at: The XVI Congress of the European Society of Cataract and Refractive Surgeons (ESCRS);September 1998; Nice, France.
6. Tetz M. Protective study on endothelial cell protection with the use of different viscoelastic agents including Healon5. Paper presented at: The XVI Congress of the European Society of Cataract and Refractive Surgeons (ESCRS); September 1998; Nice, France.
7. Arshinoff S. Viscous-retentive ophthalmic viscoelastics. Paper presented at: The XVI Congress of the European Society of Cataract and Refractive Surgeons (ESCRS);September 1998; Nice, France.
8. Holzer MP, Tetz MR, Auffarth GU,Welt R, Volcker HE. Effect of Healon5 and 4 other viscoelastic substances on intraocular pressure and endothelium after cataract surgery. J Cataract Refract Surg.2001;27(2):213-218.

Intended use statement

Healon®, Healon GV®, and Healon5® OVDs are used in ophthalmic surgical procedures to maintain deep anterior chamber, which facilitates manipulation inside the eye with reduced trauma to the corneal endothelium and other ocular tissues. Vitrax® OVD is indicated for use as a surgical aid in the following ophthalmic surgical procedures: cataract surgery with an intraocular lens, cataract surgery without an intraocular lens, secondary intraocular lens implantation, corneal transplant surgery, and glaucoma filtration surgery. Warnings/Precautions/Contraindications: There are no known contraindications to the use of Healon®, Healon GV®, Healon5®, and Vitrax® ophthalmic viscoelastic devices when used as recommended. Please refer to package inserts for full prescribing information. Rx only.